The information on this site is tailored to Florida healthcare providers under Senate Bill SB1768.
By continuing, you confirm that:
You understand the material is intended for Florida physicians only.

Dr. David Karli, MD, MBA is a regenerative medicine physician, biotech entrepreneur, and founder of Greyledge Technologies and Karli Health Institute in Miami, Florida. A former physician partner at the internationally renowned Steadman Clinic and former Clinical Instructor at Harvard Medical School’s Department of Physical Medicine & Rehabilitation, Dr. Karli’s work focuses on advancing precision applications of autologous cell therapies and orthobiologics for musculoskeletal repair, human performance, and longevity medicine.
Through Greyledge Technologies—an FDA-registered biotechnology company he founded in 2010 - Dr. Karli has pioneered data-driven approaches to regenerative medicine, including cellular phenotype quantification, dose-response optimization, and AI-driven predictive modeling of treatment outcomes. He has published research, contributed textbook chapters, and lectured extensively on the need for rigorous quality control, standardized best practices, and data-driven innovation to advance the safety, predictability, and reproducibility of cellular therapies.